BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Means C. Letter to the Editor: Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy. Metabolism. 2020;108:154254. [PMID: 32360397 DOI: 10.1016/j.metabol.2020.154254] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Ajele WK, Babalola OB, Idehen EE, Oladejo TA. Relationship between depression and psychological well-being among persons with diabetes during COVID-19 pandemic: diabetes distress as a mediator. J Diabetes Metab Disord 2022;21:631-5. [PMID: 35402318 DOI: 10.1007/s40200-022-01025-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Abed Alah M, Abdeen S, Kehyayan V, Bougmiza I. Impact of COVID-19 related home confinement measures on the lifestyle, body weight, and perceived glycemic control of diabetics. Metabol Open 2021;12:100144. [PMID: 34734171 DOI: 10.1016/j.metop.2021.100144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yin Y, Rohli KE, Shen P, Lu H, Liu Y, Dou Q, Zhang L, Kong X, Yang S, Jia P. The epidemiology, pathophysiological mechanisms, and management toward COVID-19 patients with Type 2 diabetes: A systematic review. Prim Care Diabetes 2021;15:899-909. [PMID: 34600859 DOI: 10.1016/j.pcd.2021.08.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Viurcos-Sanabria R, Escobedo G. Immunometabolic bases of type 2 diabetes in the severity of COVID-19. World J Diabetes 2021; 12(7): 1026-1041 [PMID: 34326952 DOI: 10.4239/wjd.v12.i7.1026] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Tamura RE, Said SM, de Freitas LM, Rubio IGS. Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies. Diabetol Metab Syndr 2021;13:76. [PMID: 34256824 DOI: 10.1186/s13098-021-00695-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
6 Wang J, Meng W. COVID-19 and diabetes: the contributions of hyperglycemia. J Mol Cell Biol 2020;12:958-62. [PMID: 33002109 DOI: 10.1093/jmcb/mjaa054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
7 Abdel-Moneim A, Hosni A. Insights into the possible impact of COVID-19 on the endocrine system. Arch Physiol Biochem 2021;:1-9. [PMID: 33653188 DOI: 10.1080/13813455.2021.1890131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
8 Guo Z, Jiang S, Li Z, Chen S. Metabolic Syndrome “Interacts” With COVID-19. BIO Integration 2021;1:168-77. [DOI: 10.15212/bioi-2020-0035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia. Metabolism 2021;114:154417. [PMID: 33157081 DOI: 10.1016/j.metabol.2020.154417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Singer M. Deadly Companions: COVID-19 and Diabetes in Mexico. Med Anthropol 2020;39:660-5. [PMID: 33064573 DOI: 10.1080/01459740.2020.1805742] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
11 Li W, Thomas R, El-askary H, Piechota T, Struppa D, Abdel Ghaffar KA. Investigating the Significance of Aerosols in Determining the Coronavirus Fatality Rate Among Three European Countries. Earth Syst Environ 2020;4:513-22. [DOI: 10.1007/s41748-020-00176-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
12 de Siqueira JVV, Almeida LG, Zica BO, Brum IB, Barceló A, de Siqueira Galil AG. Impact of obesity on hospitalizations and mortality, due to COVID-19: A systematic review. Obes Res Clin Pract 2020;14:398-403. [PMID: 32736969 DOI: 10.1016/j.orcp.2020.07.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 29.5] [Reference Citation Analysis]
13 Chen Y, Chen J, Gong X, Rong X, Ye D, Jin Y, Zhang Z, Li J, Guo J. Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study. Engineering (Beijing) 2020;6:1170-7. [PMID: 32837747 DOI: 10.1016/j.eng.2020.05.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
14 Chatterjee S, Ghosh R, Biswas P, Dubey S, Guria RT, Sharma CB, Kalra S. COVID-19: the endocrine opportunity in a pandemic. Minerva Endocrinol 2020;45:204-27. [PMID: 32548995 DOI: 10.23736/S0391-1977.20.03216-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]